120 related articles for article (PubMed ID: 34852986)
1. Investigation of discordant sibling pairs from hereditary breast cancer families and analysis of a rare PMS1 variant.
Landry KK; Seward DJ; Dragon JA; Slavik M; Xu K; McKinnon WC; Colello L; Sweasy J; Wallace SS; Cuke M; Wood ME
Cancer Genet; 2022 Jan; 260-261():30-36. PubMed ID: 34852986
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
4. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
5. Clustering of known low and moderate risk alleles rather than a novel recessive high-risk gene in non-BRCA1/2 sib trios affected with breast cancer.
Hilbers FS; van 't Hof PJ; Meijers CM; Mei H; Michailidou K; Dennis J; Hogervorst FBL; Nederlof PM; van Asperen CJ; Devilee P
Int J Cancer; 2020 Nov; 147(10):2708-2716. PubMed ID: 32383162
[TBL] [Abstract][Full Text] [Related]
6. Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases.
Hamdi Y; Boujemaa M; Ben Rekaya M; Ben Hamda C; Mighri N; El Benna H; Mejri N; Labidi S; Daoud N; Naouali C; Messaoud O; Chargui M; Ghedira K; Boubaker MS; Mrad R; Boussen H; Abdelhak S;
J Transl Med; 2018 Jun; 16(1):158. PubMed ID: 29879995
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing of Finnish hereditary breast cancer families.
Määttä K; Rantapero T; Lindström A; Nykter M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J
Eur J Hum Genet; 2016 Jan; 25(1):85-93. PubMed ID: 27782108
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review.
Li X; Wu Y; Suo P; Liu G; Li L; Zhang X; Chen S; Xu M; Song L
Medicine (Baltimore); 2020 Jan; 99(5):e19076. PubMed ID: 32000458
[TBL] [Abstract][Full Text] [Related]
9. Exonic sequencing and MLH3 gene expression analysis of breast cancer patients.
Khailany RA; Ozaslan M
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):35-43. PubMed ID: 34933735
[TBL] [Abstract][Full Text] [Related]
10. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
[TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism.
Cunha MLR; Meijers JCM; Rosendaal FR; Vlieg AVH; Reitsma PH; Middeldorp S
PLoS One; 2017; 12(11):e0187699. PubMed ID: 29117201
[TBL] [Abstract][Full Text] [Related]
12. A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.
Jiang Y; Sun Y; Hu J; Yu N; Liu H; Fan J; Ning X; Li Y; Liu B; Sun Y; Zhang J; Qiu X; Fu S; Zhou C; Xu H
BMC Cancer; 2019 Jun; 19(1):613. PubMed ID: 31226964
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing identifies a recurrent variant in SERPINA3 associating with hereditary susceptibility to breast cancer.
Koivuluoma S; Tervasmäki A; Kauppila S; Winqvist R; Kumpula T; Kuismin O; Moilanen J; Pylkäs K
Eur J Cancer; 2021 Jan; 143():46-51. PubMed ID: 33279852
[TBL] [Abstract][Full Text] [Related]
14. The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia.
Hori M; Takahashi A; Son C; Ogura M; Harada-Shiba M
Lipids Health Dis; 2020 Apr; 19(1):62. PubMed ID: 32252761
[TBL] [Abstract][Full Text] [Related]
15. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
17. Whole Exome Sequencing and Segregation Analysis Confirms That a Mutation in COL17A1 Is the Cause of Epithelial Recurrent Erosion Dystrophy in a Large Dominant Pedigree Previously Mapped to Chromosome 10q23-q24.
Lin BR; Le DJ; Chen Y; Wang Q; Chung DD; Frausto RF; Croasdale C; Yee RW; Hejtmancik FJ; Aldave AJ
PLoS One; 2016; 11(6):e0157418. PubMed ID: 27309958
[TBL] [Abstract][Full Text] [Related]
18. Hereditary genes and SNPs associated with breast cancer.
Mahdi KM; Nassiri MR; Nasiri K
Asian Pac J Cancer Prev; 2013; 14(6):3403-9. PubMed ID: 23886119
[TBL] [Abstract][Full Text] [Related]
19. Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Felicio PS; Grasel RS; Campacci N; de Paula AE; Galvão HCR; Torrezan GT; Sabato CS; Fernandes GC; Souza CP; Michelli RD; Andrade CE; Barros BDF; Matsushita MM; Revil T; Ragoussis J; Couch FJ; Hart SN; Reis RM; Melendez ME; Tonin PN; Carraro DM; Palmero EI
Hum Mutat; 2021 Mar; 42(3):290-299. PubMed ID: 33326660
[TBL] [Abstract][Full Text] [Related]
20. Utilizing RNA and outlier analysis to identify an intronic splice-altering variant in AP4S1 in a sibling pair with progressive spastic paraplegia.
McCullough CG; Szelinger S; Belnap N; Ramsey K; Schrauwen I; Claasen AM; Burke LW; Siniard AL; Huentelman MJ; Narayanan V; Craig DW
Hum Mutat; 2020 Feb; 41(2):412-419. PubMed ID: 31660686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
